STOCK TITAN

Hims & Hers (NYSE: HIMS) CFO sells shares in 10b5-1 plan

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that its Chief Financial Officer, Oluyemi Okupe, executed several equity transactions. On August 17, 2026, he exercised 9,388 stock options for Class A Common Stock at an exercise price of $5.01 per share, then sold 9,388 shares of Class A Common Stock at a weighted average price of $27.8869 per share pursuant to a Rule 10b5-1 trading plan. The underlying stock option award is fully vested, with 85,810 options reported as held directly after the exercise.

On August 14, 2026, multiple tranches of Restricted Stock Units (RSUs) vested and converted into an aggregate of 71,616 shares of Class A Common Stock, reflecting several service-based RSU awards that vest in substantially equal quarterly installments over four-year periods starting on June 15 of 2023, 2024, 2025, and 2026. In connection with this vesting, 36,437 shares of Class A Common Stock were withheld by the company at $28.15 per share to cover tax withholding obligations. Earlier, on June 18, 2026, Okupe sold 55,383 shares of Class A Common Stock at a weighted average price of $35.09 per share, also under the same Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Okupe Oluyemi
Role Chief Financial Officer
Sold 64,771 shs ($2.21M)
Approx. gross sale proceeds $2.21M
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F10 9,388 $0.00 $0.00
Exercise Class A Common Stock F1 9,388 $5.01 $47K
Sale Class A Common Stock F1, F5 9,388 $27.8869 $262K
Exercise Restricted Stock Unit F3, F6 18,335 $0.00 $0.00
Exercise Restricted Stock Unit F3, F7 22,988 $0.00 $0.00
Exercise Restricted Stock Unit F3, F8 11,482 $0.00 $0.00
Exercise Restricted Stock Unit F3, F9 18,811 $0.00 $0.00
Exercise Class A Common Stock F3 71,616 -- --
Tax Withholding Class A Common Stock F4 36,437 $28.15 $1.03M
Sale Class A Common Stock F1, F2 55,383 $35.09 $1.94M
Holdings After Transaction: Restricted Stock Unit — 552,779 shares (Direct); Stock Option (right to buy) — 85,810 shares (Direct); Class A Common Stock — 264,117 shares (Direct)
Footnotes (10)
  1. F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
  2. F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.95 - $35.36. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. F3. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
  4. F4. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
  5. F5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.59 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. F6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.
  7. F7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
  8. F8. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
  9. F9. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.
  10. F10. This stock option award is fully vested.
Options exercised 9,388 shares Stock options for Class A Common Stock exercised on August 17, 2026
Option exercise price $5.01 per share Exercise price for 9,388 stock options converted on August 17, 2026
Shares sold 2026-08-17 9,388 shares Class A Common Stock sold at weighted average price of $27.8869
Weighted average sale price 2026-08-17 $27.8869 per share Open-market sale of 9,388 shares under Rule 10b5-1 trading plan
RSU shares vested and settled 71,616 shares Class A Common Stock from RSU conversions on August 14, 2026
Shares withheld for taxes 36,437 shares Class A Common Stock withheld at $28.15 per share for tax withholding
Shares sold 2026-06-18 55,383 shares Class A Common Stock sold at weighted average price of $35.09
Options held after exercise 85,810 options Stock options reported as held directly following August 17, 2026 exercise
Rule 10b5-1 trading plan regulatory
"exercises and sales were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Restricted Stock Units ("RSUs") financial
"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
service-based vesting requirement financial
"The RSUs are subject to a service-based vesting requirement, which shall be satisfied"
weighted price financial
"Price reported constitutes the average weighted price of shares sold"
tax withholding obligations financial
"shares were withheld by the issuer to cover tax withholding obligations"

FAQ

What insider transactions did the HIMS CFO report on this Form 4?

The CFO of Hims & Hers Health, Inc. reported option exercises, RSU vesting, related tax-share withholding, and open-market sales of Class A Common Stock, all executed under a Rule 10b5-1 trading plan adopted on May 21, 2025.

How many HIMS shares did the CFO sell, and at what prices?

The CFO sold 55,383 shares on June 18, 2026 at a weighted average price of $35.09, and 9,388 shares on August 17, 2026 at a weighted average price of $27.8869, with both sale price ranges disclosed in the footnotes.

What equity awards in HIMS did the CFO exercise or vest in this period?

He exercised 9,388 stock options at an exercise price of $5.01 per share and had RSUs convert into 71,616 shares of Class A Common Stock, representing multiple service-based RSU awards vesting quarterly over four-year schedules.

How many HIMS stock options does the CFO hold after these transactions?

After the August 17, 2026 option exercise, the filing reports the CFO directly holding 85,810 stock options from the referenced award, which is described as fully vested in the related footnote.

Were the HIMS CFO’s trades made under a Rule 10b5-1 trading plan?

Yes. A footnote states the stock option exercises and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025, indicating the trades followed a pre-arranged plan.

How were taxes handled on the HIMS CFO’s RSU vesting?

In connection with RSU vesting on August 14, 2026, 36,437 shares of Class A Common Stock were withheld by the issuer at $28.15 per share to cover tax withholding obligations related to the RSU settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Okupe Oluyemi

(Last)(First)(Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CALIFORNIA 94123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/18/2026S(1)55,383D$35.09(2)228,938D
Class A Common Stock08/14/2026M71,616A(3)300,554D
Class A Common Stock08/14/2026F36,437(4)D$28.15264,117D
Class A Common Stock08/17/2026M(1)9,388A$5.01273,505D
Class A Common Stock08/17/2026S(1)9,388D$27.8869(5)264,117D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(3)08/14/2026M18,335 (6) (6)Class A Common Stock18,335$036,669D
Restricted Stock Unit(3)08/14/2026M22,988 (7) (7)Class A Common Stock22,988$0137,929D
Restricted Stock Unit(3)08/14/2026M11,482 (8) (8)Class A Common Stock11,482$0114,825D
Restricted Stock Unit(3)08/14/2026M18,811 (9) (9)Class A Common Stock18,811$0263,356D
Stock Option (right to buy)$5.0108/17/2026M(1)9,388 (10)02/23/2032Class A Common Stock9,388$085,810D
Explanation of Responses:
1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.95 - $35.36. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
4. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.59 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.
7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
8. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
9. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.
10. This stock option award is fully vested.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)